<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Cereb Blood Flow Metab</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Cereb. Blood Flow Metab</journal-id>
<journal-id journal-id-type="publisher-id">JCB</journal-id>
<journal-id journal-id-type="hwp">spjcb</journal-id>
<journal-title-group>
<journal-title>Journal of Cerebral Blood Flow &amp; Metabolism</journal-title>
</journal-title-group>
<issn pub-type="ppub">0271-678X</issn>
<issn pub-type="epub">1559-7016</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27117856</article-id>
<article-id pub-id-type="pmc">5363467</article-id>
<article-id pub-id-type="doi">10.1177/0271678X16646788</article-id>
<article-id pub-id-type="publisher-id">10.1177_0271678X16646788</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Depiction of microglial activation in aging and dementia: Positron emission tomography with [<sup>11</sup>C]DPA713 versus [<sup>11</sup>C](<italic>R</italic>)PK11195</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yokokura</surname>
<given-names>Masamichi</given-names>
</name>
<xref ref-type="aff" rid="aff1-0271678X16646788">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Terada</surname>
<given-names>Tatsuhiro</given-names>
</name>
<xref ref-type="aff" rid="aff2-0271678X16646788">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bunai</surname>
<given-names>Tomoyasu</given-names>
</name>
<xref ref-type="aff" rid="aff2-0271678X16646788">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nakaizumi</surname>
<given-names>Kyoko</given-names>
</name>
<xref ref-type="aff" rid="aff1-0271678X16646788">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Takebayashi</surname>
<given-names>Kiyokazu</given-names>
</name>
<xref ref-type="aff" rid="aff1-0271678X16646788">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Iwata</surname>
<given-names>Yasuhide</given-names>
</name>
<xref ref-type="aff" rid="aff1-0271678X16646788">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yoshikawa</surname>
<given-names>Etsuji</given-names>
</name>
<xref ref-type="aff" rid="aff3-0271678X16646788">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Futatsubashi</surname>
<given-names>Masami</given-names>
</name>
<xref ref-type="aff" rid="aff3-0271678X16646788">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Suzuki</surname>
<given-names>Katsuaki</given-names>
</name>
<xref ref-type="aff" rid="aff1-0271678X16646788">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mori</surname>
<given-names>Norio</given-names>
</name>
<xref ref-type="aff" rid="aff1-0271678X16646788">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ouchi</surname>
<given-names>Yasuomi</given-names>
</name>
<xref ref-type="aff" rid="aff2-0271678X16646788">2</xref>
<xref ref-type="corresp" rid="corresp1-0271678X16646788"></xref>
</contrib>
</contrib-group>
<aff id="aff1-0271678X16646788"><label>1</label>Department of Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan</aff>
<aff id="aff2-0271678X16646788"><label>2</label>Department of Biofunctional Imaging, Hamamatsu University School of Medicine, Hamamatsu, Japan</aff>
<aff id="aff3-0271678X16646788"><label>3</label>Central Research Laboratory, Hamamatsu Photonics K.K., Hamamatsu, Japan</aff>
<author-notes>
<corresp id="corresp1-0271678X16646788">Yasuomi Ouchi, Department of Biofunctional Imaging, Medical Photonics Research Center, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu 431-3192, Japan. Email: <email>ouchi@hama-med.ac.jp</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>7</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>3</month>
<year>2017</year>
</pub-date>
<volume>37</volume>
<issue>3</issue>
<fpage>877</fpage>
<lpage>889</lpage>
<history>
<date date-type="received">
<day>25</day>
<month>8</month>
<year>2015</year>
</date>
<date date-type="rev-recd">
<day>21</day>
<month>3</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>3</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2016</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder content-type="society">International Society for Cerebral Blood Flow and Metabolism</copyright-holder>
</permissions>
<abstract>
<p>The presence of activated microglia in the brains of healthy elderly people is a matter of debate. We aimed to clarify the degree of microglial activation in aging and dementia as revealed by different tracers by comparing the binding potential (BP<sub>ND</sub>) in various brain regions using a first-generation translocator protein (TSPO) tracer [<sup>11</sup>C](<italic>R</italic>)PK11195 and a second-generation tracer [<sup>11</sup>C]DPA713. The BP<sub>ND</sub> levels, estimated using simplified reference tissue models, were compared among healthy young and elderly individuals and patients with Alzheimer’s disease (AD) and were correlated with clinical scores. An analysis of variance showed category-dependent elevation in levels of [<sup>11</sup>C]DPA713 BP<sub>ND</sub> in all brain regions and showed a significant increase in the AD group, whereas no significant changes among groups were found when [<sup>11</sup>C](<italic>R</italic>)PK11195 BP<sub>ND</sub> was used. Cognito-mnemonic scores were significantly correlated with [<sup>11</sup>C]DPA713 BP<sub>ND</sub> levels in many brain regions, whereas [<sup>11</sup>C](<italic>R</italic>)PK11195 BP<sub>ND</sub> failed to correlate with the scores. As mentioned elsewhere, the present results confirmed that the second-generation TSPO tracer [<sup>11</sup>C]DPA713 has a greater sensitivity to TSPO in both aging and neuronal degeneration than [<sup>11</sup>C](<italic>R</italic>)PK11195. Positron emission tomography with [<sup>11</sup>C]DPA713 is suitable for the delineation of in vivo microglial activation occurring globally over the cerebral cortex irrespective of aging and degeneration.</p>
</abstract>
<kwd-group>
<kwd>Aging</kwd>
<kwd>brain imaging</kwd>
<kwd>dementia</kwd>
<kwd>microglia</kwd>
<kwd>positron emission tomography</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>